ML335 - Potassium Channel Activator - 生命科學(xué)試劑 - MedChemExpress_第1頁(yè)
ML335 - Potassium Channel Activator - 生命科學(xué)試劑 - MedChemExpress_第2頁(yè)
ML335 - Potassium Channel Activator - 生命科學(xué)試劑 - MedChemExpress_第3頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEML335Cat. No.: HY-104005CAS No.: 825658-06-8分式: CHClNOS分量: 373.25作靶點(diǎn): Potassium Channel作通路: Membrane Transporter/Ion Channel儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 155 mg/mL (415.27

2、 mM; Need ultrasonic and warming)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 2.6792 mL 13.3958 mL 26.7917 mL5 mM 0.5358 mL 2.6792 mL 5.3583 mL10 mM 0.2679 mL 1.3396 mL 2.6792 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。BIOLOGICAL ACTIVITY物活性 ML335是TREK-1 和 TREK-2 的選擇性激活劑。IC50 & Target TREK-

3、1, TREK-2體外研究Xenopus oocyte two-electrode voltage-clamp measurements show that ML335 and ML402 activate K2P2.1and K2P10.1 but not K2P4.1 (14.32.7M, K2P2.1-ML335; 13.77.0M, K2P2.1-ML402; 5.20.5M,K2P10.1-ML335; and 5.91.6M, K2P10.1-ML402). Swapping the Lys271 equivalent between K2P2.1 and1/2 Master of

4、 Small Molecules 您邊的抑制劑師www.MedChemEK2P4.1 results in a clear phenotype reversal for ML335 and M402 activation. ML335 and ML402 activateK2P2.1 in HEK293 cells similar to their effects in Xenopus oocytes (5.20.8M and 5.91.6M for ML335and ML402, respectively (n3) 1.PROTOCOLCell Assay 1 Mouse K2P2.1, h

5、uman K2P4.1, and mutants are expressed from a previously described pIRES2-EGFPvector in HEK293T cells (ATTC). 70% confluent cells are transfected (in 35-mm diameter wells) withLipofectAMINE 2000 for 6h, and plated onto coverslips coated with Matrigel. Effects of ML335, ML402 andarachidonic acid on K

6、2P2.1 current at 0mV are measured by whole-cell patch-clamp experiments 24h aftertransfection. Acquisition and analysis are performed using pCLAMP9 and an Axopatch 200B amplifier.Pipette resistance ranges from 1 to 1.5M. Pipette solution contains the following: 145mM KCl, 3mMMgCl2, 5mM EGTA and 20mM

7、 HEPES (pH 7.2 with KOH). Bath solution contains the following: 145mMNaCl, 5mM KCl, 1mM CaCl2, 3mM MgCl2 and 20mM HEPES (pH 7.4 with NaOH). K2P2.1 currents areelicited by a 1s ramp from -100 to +50mV from a -80mV holding potential. After stabilization of the basalcurrent, ML335 and ML402 are perfuse

8、d at 200mL per hour until potentiation is stably reached 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Lolicato M, et al. K2P2.1 (TREK-1)-activator complexes reveal a cryptic selectivity filter binding site. Nature. 2017 Jul 20;547(7663):364-368.McePdfHeightCaution: Product has not been fully validated for medical application

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論